No additional copies of HERV-Fc1 in the germ line of multiple sclerosis patients by Kari K Nissen et al.
SHORT REPORT Open Access
No additional copies of HERV-Fc1 in the germ line
of multiple sclerosis patients
Kari K Nissen1*, Magdalena J Laska1, Bettina Hansen1, Finn S Pedersen2 and Bjørn A Nexø1
Abstract
Background: Human endogenous retroviruses (HERVs) are suspected to play a role in the development of multiple
sclerosis (MS). This suspicion has in part been based on increased expression of viral RNA or proteins or antibodies
targeting retroviral products in MS patients. Recently, our group provided genetic evidence for association between
the endogenous retrovirus HERV-Fc1 and MS, suggesting that HERV-Fc1 plays a role in this multifactorial disease.
We have found increased expression of HERV-Fc1 in MS patients suffering from recent attack, but the underlying
mechanism for association is still unknown.
Findings: Evidence from animal models indicates that ERV implication in the pathogenesis of diseases can be a
result of extra copies of the virus in the germ line. Therefore, we investigated the genome of 81 individuals, 74
patients with MS and 7 healthy controls, by means of Southern blotting, for presence of extra HERV-Fc1 copies. The
known insertion at the Xq21.33 position was readily detectable, but no additional insertions in other genomic
contexts could be identified in any studied individuals. This substantiates our previous copy-number PCR findings of
a 2:1 ratio of HERV-Fc1 DNA between women and men, as expected from the X-chromosome location; there was
no difference between patient and control individuals.
Conclusions: No additional germ line copies of HERV-Fc1 could be identified, precluding such copies to underlie
the association between this provirus and multiples sclerosis.
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Findings
Background
Retrovirus-like elements including human endogenous
retroviruses (HERVs) occupy around 8 percent of the
human genome [1]. Most of these ancient viral elements
are disrupted by accumulated mutations and are there-
fore generally considered harmless. However, about 50
HERVs retain coding potential [2], and a realization of
their potential in pathogenesis is growing. Many studies
have thus presented different HERVs, especially of
HERV-W and HERV-H descent, to be functionally asso-
ciated with multiple sclerosis (MS), a multifactorial dis-
ease with both environmental and genetic factors
involved, most of which are still obscure. These associa-
tions have been described as increased expression of
viral RNA or proteins from HERVs or increased load of
host antibodies targeting these have been demonstrated
in MS patients [3-6]. For ubiquitous genomic elements
like HERVs, the cause-or-consequence relation of such
functional correlations can be hard to establish [7]. By
investigating HERVs from a genetic viewpoint, exploiting
genotype variations, it is possible to identify associations,
which more certainly precede the disease development.
It is unlikely that a disease can alter the organism’s se-
quence of genomic, polyclonal DNA.
Recently, we presented genetic association with MS
for the HERV-Fc1 locus located on Xq21.33 [8]. One
marker neighboring HERV-Fc1 (rs391745) had a p-value
of 1.3*10-6 for disease association and other markers in
and around the provirus were also associated with MS.
A pathogenic background for this association has not
been established, although we demonstrated an average
4 times increased expression of extracellular HERV-Fc1
gag RNA in plasma from MS patients with recent
attacks compared to patients in remission or control
persons [9]. Additional studies have shown the HERV-
Fc1–MS association to hold only for the common “bout
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onset” subtypes of sclerosis, comprising the remitting/re-
lapsing and secondary progressive forms. No association
was found for the rarer primary progressive subtype
[10]. This is particularly interesting in the light of bout
onset subtypes having an overweight of female patients,
whereas the primary progressive subtype has equal gen-
der rates. HERV-Fc1 is located on the X chromosome
and X-dominant diseases are known to be more com-
mon among females.
In the present study we were inspired by findings in
mice, where disease association with endogenous retro-
virus has been shown to correlate with increased copy-
numbers of the specific virus in the germ line. E.g. the
inherited AKR murine leukemia virus was present in more
copies in high-virus-yielding mouse strains, with high
leukemia incidence, compared to low- or non-virus-
yielding mouse strains with low leukemia risk [11]. There-
fore, we speculated whether a similar mechanism could
account for the HERV-Fc1 involvement in MS.
To date, the HERV-K family is the only family found to
have integrations specific to human [12]. Some HERV-K
viruses actually occur polymorphically in the human gen-
ome; the majority in a study population had the preinte-
gration sites, whereas 30% and 15% of the individuals
carried the integrated HERV-K113 and HERV-K115, re-
spectively [13]. Additional reports on retroviral elements
occurring polymorphic in the human genome continue to
show [14], signifying relatively recent activity of retroviral
integration mechanisms. Other such polymorphisms
might exist, yet undiscovered due to rare occurrence.
HERV-Fc1, which is part of the enlarged HERV-H/F
family, is also an evolutionarily recent genomic acquisi-
tion, present only in the genomes of human, chimpan-
zee, and gorilla [15]. HERV-Fc1 is unusual among
human provirus in having only a single known integra-
tion in the genome. It is characterized by a relatively
preserved sequence with coding-potential for Gag and
Env, only three mutations disrupting the pol gene, and
high LTR identity (94.3%), which argues that the virus
could have been recently mobile. Benit et al. have previ-
ously searched human genome databases for HERV-Fc
elements [15] and found besides the single copy HERV-
Fc1 only a related HERV-Fc2 master element of low
similarity and some truncated Fc2-like elements. Al-
though belonging to the same family, the HERV-Fc1 and
HERV-Fc2 sequences are rather dissimilar, e.g. the env
sequences show only 65% identity. The HERV-Fc family
is thus divided into subgroups, with HERV-Fc1 being
the only member of its group.
Putative copies present only in a small part of the
population may not be represented in databases. Thus, it
remains a possibility that extra copies of HERV-Fc1 seg-
regate in the human population in a minority of indivi-
duals, similar to HERV-K.
The objective of this study was to investigate whether
HERV-Fc1 association with MS could be due to new,
unidentified germ line integrations, somehow contribut-
ing to the complex disease development. Differences in
the HERV-Fc1 copy numbers could either represent
multiple integration events or amplification of the pro-
virus by retrotransposition after the initial integration.
Other groups have dealt with the hypothesis of extra
HERV copies, mainly concerning the HERV-W family
(hereunder MSRV and ERVWE1) [5,16]. Here, authors
reported an increase in HERV-W/MSRV DNA copy
number, without evidence of new integration events or
viral replication. In contrary, DNA copy numbers of
syncytin-1 (env protein of the ERVWE1) were reported
to be unchanged. Perron et al. reported the level of cop-
ies increased rather noticeably as the disease underwent
the development from RRMS to SPMS [5]. Thus, it is
unlikely that these findings represent extra germ line
copies, rather the possibility of re-integrations in individ-
ual cells.
Furthermore, these studies have all made use of quan-
titative PCR in the copy-number determination. We
aimed for a different technique, Southern blotting, which
provides qualitative rather than quantitative information
on the copy number of a specific genomic sequence.
Methods, Results, and Discussion
Southern blots on genomic DNA can distinguish even
highly similar endogenized proviruses of the same family
due to the unique sequences of the flanking DNA.
Peripheral blood mononuclear cells (PBMCs) obtained
from MS patients or healthy control persons were kindly
provided by T. Christensen, A. Møller-Larsen and T.
Petersen. These primary cells were cryopreserved right
after sampling, and exposed to no further processing be-
fore extraction of genomic DNA using phenol-chloroform.
Of a total 81 samples, 74 represented genomic DNA from
diagnosed MS patients (45 females, 29 males), and 7 from
healthy control individuals (6 females, 1 male). 10 μg
DNA was digested with AflII enzyme (New England Bio-
labs, USA) and separated by 0.7% Tris-acetate-EDTA gel
electrophoresis. Control digests were performed with StuI
(NEB). As positive control, 1x, 3x, and 10x copies of AflII-
digested BAC RP11-1114 M8 was included. The DNA was
transferred to a Zeta-probe GT membrane (Biorad, USA)
by vacuum suction and prehybridized, hybridized, and
washed as previously described [17]. The DNA-probe was
amplified from BAC RP11-1114 M8 (Xq21.33 [GenBank:
AL354685]) by means of nested PCR amplifying a 403 bp
region of the HERV-Fc1 env gene found to be unique in
BLAST-search (Primers; NestedFc1-F: CTCCCCATCTCT
CTGGTGC, NestedFc1-R: TGAGGAGGCTGGTTTCTA
CTAAG). Prior to hybridization, the probe was α32
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P-dCTP-labeled by means of Prime-it II Random Primer
Labeling Kit (Agilent Technologies, USA).
To test the specificity of the reaction, we first hybri-
dized canine DNA (D17 cell line); there was absolutely
no reaction to this DNA. HERV-Fc1-like elements have
been described in the canine genome [18], but BLAST-
searches show minor similarity between the human
ERV-Fc1 env gene (SB-probe hybridization site) and the
canine ERV-Fc1 env.
A representative Southern blot with human DNAs is
presented in Figure 1A. Among the 81 genomic DNAs
analyzed, the expected HERV-Fc1 integration at position
Xq21.33 was always readily detectable migrating as a
4313 bp band as predicted for AflII digestion. Control
digests with an alternative enzyme, StuI, resulted in pre-
dicted migration of 7752 bp, confirming hybridization to
the true Fc1 env sequence. However, no additional inte-
gration sites were identified in any samples.
To verify that we were indeed able to detect several cop-
ies of a provirus with many integration sites, we designed a
398 bp probe targeting the env gene in viruses of the
HERV-K family (BAC RP11-749 M10 (1q23.3, [GenBank:
AF012336.2]), primers; HERV-K18-F: GCCTCGCCATC
CATCCATATT, HERV-K18-R: GCGTCTAACCATGTCC
CAGTG). This HERV family has numerous copies in the
human genome, and the relative recent integration is
reflected in the high sequence similarity of proviruses of
this family. The probe had 96-100% homology to at least
HERV-K18, -K113, and -K115 but hybridization to a num-
ber of additional HERV-Ks was expected and seen (BLAST
search identified >10 positions in the human genome with
>95% probe-identity), Figure 1B.
The Southern blot method is qualitative rather than
quantitative and not suited for actual copy-number esti-
mations based on band intensity. Instead, it is an ideal
tool for analyzing the potential integration of viral se-
quence to unknown chromosomal areas, since new inte-
grations will be apparent from the diverse migration
distances. Moreover, although the Southern probe hybri-
dizes to highly homologous sequences, the length of the
probe allows some deviation and will therefore recognize
related sequences with some variation. This is relevant
in the context of endogenized retroviruses, where muta-
tions tend to accumulate in time after integration.
A limitation of this method is the incapacity of detecting
un-integrated (circular) virus specimens and duplication
of larger chromosomal areas encompassing the external
restriction site. In our recent study of HERV-Fc1 expres-
sion, the HERV-Fc1 copy-number was analyzed based on
quantitative real-time PCR [9]. The DNA analyzed in this
context originated from another group of study indivi-
duals, including 31 MS patients and 30 healthy control
persons. Genomic DNA from all persons derived from
PBMCs was amplified and the copy-number estimated
from the standard (a linearized plasmid containing the
HERV-Fc1 sequence). This study showed an average
9.3x103 HERV-Fc1 Gag copies/μl in women and 4.5x103
copies/μl in men (in 40 ng/μl samples), irrespective of pa-
tient or control status. The 2:1 ratio between women and
men confirms the specificity of the assay from the X-
chromosomal location of the HERV-Fc1 locus.
The combined results support the notion that no add-
itional copies of HERV-Fc1 exist. We therefore conclude
that extra germ line copies of HERV-Fc1 are not a
Figure 1 Representative Southern blot. Seven samples of genomic DNA digested with AflII (Lane A-G) or StuI (Lane H, same DNA as in
G). Lane I-K = AflII digested RP11-1114 M8 BAC 1x, 3x, and 10xcopies respectively. A HERV-Fc1 env probe, B HERV-K family env probe. Only one
genomic insertion is found for HERV-Fc1, whereas numerous integrated viruses are detected by the HERV-K probe.
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common phenomenon in MS patients and can thus be
ruled out as a potential contributor to the development
of multiple sclerosis.
Our main focus has been on MS patients from the
perspective that a variation involved in disease develop-
ment should mainly be represented in this population
group. Since the subtype diagnosis was not available for
all patients, the samples have not been stratified, but all
subtypes were represented in the study. Since HERV-Fc1
is associated genetically to bout onset MS, this subtype
is of direct interest. However, it could be argued that the
lack of association with primary progressive MS renders
it more likely that an endogenous retroviral element
similar to HERV-Fc1 but not located on the X chromo-
some could be involved in this subtype. The control
group was matched on geographical and ethnical origin,
belonging to an age-interval matching the patient group.
Even though we have not found any new integration
in this study, it must be emphasized that our experi-
ments do not exclude non-clonal integrations as a result
of replication in somatic cells of the individual person.
Also, we cannot exclude the possibility that additional
copies of HERV-Fc1 segregate in a very small minority
of the population, and could be related to other diseases.
If so, it would not be expected to be involved in develop-
ment of multiple sclerosis. Future studies will investigate
alternative mechanism as to how HERV-Fc1 could be a
contributor to increased risk of developing multiple
sclerosis and potentially other autoimmune diseases.
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